Updated October 2026
If you’ve read anything about CBD, you’ve probably seen the phrase “endocannabinoid system,” often shortened to ECS. It’s a real part of human biology, and scientists have learned a lot about it over the last few decades. It’s also a place where marketing tends to get ahead of the science.
This guide explains what the ECS is, how it works, and what researchers have actually found about how CBD interacts with it. We’ve tried to be clear about where the evidence is strong and where it isn’t.
What is the endocannabinoid system?
The ECS is a signaling system found throughout the body. Researchers describe it as having three main parts: cannabinoid receptors, the body’s own cannabinoid-like molecules (called endocannabinoids), and the enzymes that make and break down those molecules.[1]
It got its name because scientists discovered it while studying how THC, the intoxicating compound in cannabis, acts on the body. The system itself isn’t about cannabis. Your body runs it whether or not you’ve ever used a cannabis product.
The three main parts
1. Endocannabinoids: the messengers
The two best-studied endocannabinoids are anandamide and 2-AG (short for 2-arachidonoyl glycerol).[1] They’re made from fats in your cell membranes.
Unlike many chemical messengers, which are made ahead of time and stored, endocannabinoids are made on demand and released quickly when a cell is triggered.[1] In the brain, researchers think 2-AG in particular often acts as a “retrograde” messenger. It travels backward from the receiving nerve cell to the sending one and helps turn down the signal.[1]
2. Receptors: where the messages land
The two best-known receptors are CB1 and CB2.
- CB1 is abundant in the brain and nervous system, especially in areas involved in thinking, movement, memory and coordination.[1] It’s also found in other tissues.
- CB2 is found at much lower levels in the brain. There it sits mainly on immune-type cells called microglia and on blood vessels.[1] Outside the brain, it’s best known for its presence on immune cells.
Some endocannabinoids also act on other receptors, including a channel called TRPV1.[1] So the ECS isn’t a closed loop of just two receptors.
3. Enzymes: the clean-up crew
Endocannabinoid signals are short-lived because enzymes break them down. This is one place where many CBD articles, including an older version of this one, get the details wrong.
Anandamide and 2-AG are broken down by different enzymes:
- Anandamide is broken down mainly by an enzyme called FAAH (fatty acid amide hydrolase).[1]
- 2-AG is broken down mainly by MAGL (monoacylglycerol lipase), with help from two other enzymes, ABHD6 and ABHD12.[1] In one study of mouse brain tissue, MAGL accounted for about 85% of 2-AG breakdown activity.[2]
Researchers also point out that 2-AG is part of the body’s wider fat metabolism. Changing how it’s made or broken down can have effects well beyond the ECS.[1] That’s a good reminder that the ECS doesn’t work in isolation. It’s connected to many other systems in the body.
What does the ECS do?
The ECS is involved in a wide range of the body’s functions. One 2024 review lists pain signaling, appetite, memory and learning, immune response, fertility and reproduction, and how the body handles sugar and fat.[7]
Being involved in something isn’t the same as controlling it, though. Most of what we know comes from lab and animal research, and from studying what happens when the system is blocked or overstimulated. Researchers are still working out what the ECS does in people day to day. So treat confident claims that the ECS “keeps your whole body in perfect balance” with some caution.
How does CBD affect the ECS?
CBD (cannabidiol) behaves very differently from THC. THC activates the CB1 receptor directly, which is a big part of why it causes a high. CBD doesn’t work that way.
Here’s what lab studies have found:
- CB1: In a 2015 study of lab-grown cells, CBD acted as a negative allosteric modulator of CB1. In plain terms, it attached to a different spot on the receptor and turned down the receptor’s response to other molecules, including THC.[3] This was measured in cells, not in people.
- Other receptors: Lab studies have found that CBD activates the TRPV1 receptor.[4] It also acts as a modest agonist at a serotonin receptor called 5-HT1A.[5] The 5-HT1A finding came from cell-culture work.[5]
- Endocannabinoid breakdown: In a 2001 lab study, CBD only weakly inhibited the breakdown of anandamide.[4] You’ll often see this described as CBD “boosting your endocannabinoids.” The evidence for that in people is much thinner than the claim.
Does CBD cancel out THC? Not reliably. Controlled human studies have found that CBD sometimes softens THC’s effects and sometimes makes them stronger.[6] In a 2023 randomized trial, 18 healthy adults ate brownies containing 20 mg of THC, with or without 640 mg of CBD.[6] With the high CBD dose, participants had stronger THC effects, not weaker ones.[10] The researchers linked this to CBD slowing the body’s breakdown of THC.[10] That dose of CBD is far higher than what’s in a typical serving of a retail product. But it’s a good reason not to assume CBD protects you from THC.
What this means if you use CBD
The science of the ECS is real and interesting. But knowing how CBD acts on a receptor in a lab dish doesn’t tell you what a particular product will do for you. No over-the-counter CBD product has been shown to “optimize” or “balance” the endocannabinoid system. We won’t claim ours does.
What you can check is what’s actually in the bottle. OnlyPure posts a certificate of analysis (COA) from an independent lab for each product. Our CBD Tincture and CBD Softgels are made with full-spectrum hemp extract. For example, the current 1500 mg tincture report (lot 251210-2) lists small amounts of CBG, CBC, CBDV and THC alongside CBD. Each product’s COA shows exactly which cannabinoids the lab measured, batch by batch. You can see every report on our Product COAs page.
Before you start
- Medications: The FDA warns that CBD can cause liver injury.[8] It can also raise or lower the effects of other medicines.[8] Using CBD with alcohol or other drugs that slow brain activity raises the risk of sedation and drowsiness.[8] Talk with your doctor first.
- Pregnancy and nursing: The FDA strongly advises against using CBD, THC or marijuana in any form during pregnancy or while breastfeeding.[9]
If you have questions about a product or its lab report, contact us or browse the OnlyPure shop.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
This article is general information, not medical advice. Talk to your doctor before using CBD if you take any medication, have a medical condition, or are pregnant or nursing. Not for use by anyone under 18.
Sources
- Lu HC, Mackie K. “An Introduction to the Endogenous Cannabinoid System.” Biol Psychiatry 2016;79(7):516-525 — pmc.ncbi.nlm.nih.gov
- Blankman JL, Simon GM, Cravatt BF. “A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol.” Chem Biol 2007 (PMID 18096503; mouse brain) — pmc.ncbi.nlm.nih.gov
- Laprairie RB et al. “Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor.” Br J Pharmacol 2015 (PMID 26218440; cell culture) — pmc.ncbi.nlm.nih.gov
- Bisogno T et al. “Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.” Br J Pharmacol 2001 (PMID 11606325) — pmc.ncbi.nlm.nih.gov
- Russo EB et al. “Agonistic properties of cannabidiol at 5-HT1a receptors.” Neurochem Res 2005;30(8):1037-43 (PMID 16258853; cell culture) — link.springer.com
- Zamarripa CA et al. “Assessment of Orally Administered Δ9-THC When Coadministered With CBD…: A Randomized Clinical Trial.” JAMA Netw Open 2023;6(2):e2254752 — pmc.ncbi.nlm.nih.gov
- “The endocannabinoid system in appetite regulation and treatment of obesity.” Pharmacol Res Perspect 2024;12(5):e70009 — pmc.ncbi.nlm.nih.gov
- FDA — What You Need to Know (And What We’re Working to Find Out) About Products Containing Cannabis or Cannabis-derived Compounds, Including CBD — www.fda.gov
- FDA — What You Should Know About Using Cannabis, Including CBD, When Pregnant or Breastfeeding — www.fda.gov
- NCCIH research summary — “When Taken Orally, Δ9-THC With Cannabidiol Can Result in Stronger Drug Effects Than Δ9-THC Alone” — www.nccih.nih.gov
